{"entity":{"type":"insider","cik":"0001618275","url":"/insider/0001618275","json_url":"/insider/0001618275.json","name":"Graney Thomas","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":4,"first":"2016-02-26","last":"2018-10-02","span_basis":"filed_date"},"name_variants":[{"name":"Graney Thomas","source":"filing","n_filings":4,"first_seen":"2016-02-26","last_seen":"2018-10-02"}],"transactions":[{"id":6727266,"accession":"0001209191-18-053125","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-053125","line_url":"/filing/0001209191-18-053125#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001618275","owner_name":"Graney Thomas","owner_display_name":"Graney Thomas","owner_url":"/insider/0001618275","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1076.0,"shares_display":"1,076","price_per_share":193.24,"price_display":"193.24","price_state":"stated","total_value":207926.24,"total_display":"207,926.24","total_whole":"207,926","shares_owned_after":12430.0,"shares_owned_after_display":"12,430","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-01","filed_date":"2018-10-02","scope":"insider"},{"id":6096312,"accession":"0001209191-18-000968","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-000968","line_url":"/filing/0001209191-18-000968#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001618275","owner_name":"Graney Thomas","owner_display_name":"Graney Thomas","owner_url":"/insider/0001618275","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":777.0,"shares_display":"777","price_per_share":149.95,"price_display":"149.95","price_state":"stated","total_value":116511.15,"total_display":"116,511.15","total_whole":"116,511","shares_owned_after":8789.0,"shares_owned_after_display":"8,789","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-03","scope":"insider"},{"id":4650855,"accession":"0001209191-17-014370","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-014370","line_url":"/filing/0001209191-17-014370","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001618275","owner_name":"Graney Thomas","owner_display_name":"Graney Thomas","owner_url":"/insider/0001618275","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1874.0,"shares_display":"1,874","price_per_share":16.94,"price_display":"16.94","price_state":"stated","total_value":31745.56,"total_display":"31,745.56","total_whole":"31,746","shares_owned_after":20763.0,"shares_owned_after_display":"20,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-22","filed_date":"2017-02-24","scope":"insider","n_lines":2},{"id":2875335,"accession":"0001209191-16-103055","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-103055","line_url":"/filing/0001209191-16-103055#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001618275","owner_name":"Graney Thomas","owner_display_name":"Graney Thomas","owner_url":"/insider/0001618275","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":563.0,"shares_display":"563","price_per_share":8.5,"price_display":"8.50","price_state":"stated","total_value":4785.5,"total_display":"4,785.50","total_whole":"4,786","shares_owned_after":5137.0,"shares_owned_after_display":"5,137","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-24","filed_date":"2016-02-26","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000875320","name":"VERTEX PHARMACEUTICALS INC / MA","url":"/issuer/0000875320","role":"Officer (Chief Financial Officer)","n_filings":2,"first_seen":"2018-01-03","last_seen":"2018-10-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001446847","name":"IRONWOOD PHARMACEUTICALS INC","url":"/issuer/0001446847","role":"Officer (Chief Financial Officer)","n_filings":2,"first_seen":"2016-02-26","last_seen":"2017-02-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001618275","retrieved_at":"2026-08-22T14:40:45+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}